Found: 15
Select item for more details and to access through your institution.
Oro‐Bucco‐Lingual Dyskinesia, Weight Loss, and Cognitive Decline in Anti‐DPPX Antibody‐Mediated Encephalitis.
- Published in:
- Movement Disorders Clinical Practice, 2020, v. 7, p. S80, doi. 10.1002/mdc3.13058
- By:
- Publication type:
- Article
Mycobacterium abscessus Meningitis Associated with Stem Cell Treatment During Medical Tourism.
- Published in:
- Emerging Infectious Diseases, 2023, v. 29, n. 8, p. 1655, doi. 10.3201/eid2908.230317
- By:
- Publication type:
- Article
Usutu virus disease: a potential problem for North America?
- Published in:
- Journal of NeuroVirology, 2020, v. 26, n. 2, p. 149, doi. 10.1007/s13365-019-00818-y
- By:
- Publication type:
- Article
Two Cases of Monkeypox-Associated Encephalomyelitis - Colorado and the District of Columbia, July-August 2022.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Innovation and optimization in autoimmune encephalitis trials: the design and rationale for the Phase 3, randomized study of satralizumab in patients with NMDAR-IgG-antibody-positive or LGI1-IgG-antibody-positive autoimmune encephalitis (CIELO).
- Published in:
- Frontiers in Neurology, 2024, p. 01, doi. 10.3389/fneur.2024.1437913
- By:
- Publication type:
- Article
Correspondence to: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Evaluation of Plasma Neurofilament Light Chain Levels as a Biomarker of Neuronal Injury in the Active and Chronic Phases of Autoimmune Neurologic Disorders.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.689975
- By:
- Publication type:
- Article
Update in Autoimmune Movement Disorders: Newly Described Antigen Targets in Autoimmune and Paraneoplastic Cerebellar Ataxia.
- Published in:
- Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.683048
- By:
- Publication type:
- Article
A Longitudinal, Observational Analysis of Neuronal Injury Biomarkers in a Case Report of a Patient With Paraneoplastic Anti-CRMP5 Antibody-Associated Transverse Myelitis.
- Published in:
- Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.691509
- By:
- Publication type:
- Article
Longitudinal study of immunity to SARS‐CoV2 in ocrelizumab‐treated MS patients up to 2 years after COVID‐19 vaccination.
- Published in:
- Annals of Clinical & Translational Neurology, 2024, v. 11, n. 7, p. 1750, doi. 10.1002/acn3.52081
- By:
- Publication type:
- Article
Safety and patient experience with at‐home infusion of ocrelizumab for multiple sclerosis.
- Published in:
- Annals of Clinical & Translational Neurology, 2023, v. 10, n. 4, p. 579, doi. 10.1002/acn3.51745
- By:
- Publication type:
- Article
Update in autoimmune and paraneoplastic myelopathies: Newly described antigen targets and antibody testing.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.972143
- By:
- Publication type:
- Article
Detection of High‐Risk Paraneoplastic Antibodies against TRIM9 and TRIM67 Proteins.
- Published in:
- Annals of Neurology, 2023, v. 94, n. 6, p. 1086, doi. 10.1002/ana.26776
- By:
- Publication type:
- Article
Correspondence to: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Blood-based biomarkers of neuronal and glial injury in active major neuropsychiatric systemic lupus erythematosus.
- Published in:
- Lupus, 2024, v. 33, n. 10, p. 1116, doi. 10.1177/09612033241272961
- By:
- Publication type:
- Article